REVNEUZE

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark REVNEUZE was filed as Word mark on 01/29/2020 at the World Intellectual Property Organization.

Trademark Details Last update: May 26, 2023

Trademark form Word mark
File reference 1532461
Countries Australia Brazil Canada China European Community Japan
Base trademark US No. 88550791, July 30, 2019
Application date January 29, 2020
Expiration date September 5, 2022

Trademark owner

50 West 75th Street, Suite 105
Willowbrook IL 60527
US

Trademark representatives

Ziegler IP Law Group, LLC. 55 Greens Farms Road US

goods and services

05 Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, mixed dementia, frontotemporal dementia, dementia with Lewy bodies, vascular dementia, Wernicke-Korsakoff syndrome, Huntington's disease, Creutzfeldt Jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases

Trademark history

Date Document number Area Entry
April 12, 2023 2023/20 Gaz US RAW: Total Ceasing Effect
June 28, 2022 2022/27 Gaz CA Rejection
September 16, 2021 2021/38 Gaz CA Rejection
June 3, 2021 2021/22 Gaz JP Rejection
January 19, 2021 2021/3 Gaz BR Rejection
November 17, 2020 2020/47 Gaz AU Rejection
October 15, 2020 2020/42 Gaz EM Rejection
September 7, 2020 2020/37 Gaz CN Rejection
January 29, 2020 2020/20 Gaz US Registration

ID: 141532461